Advertisement
Advertisement

ANVS

ANVS logo

Annovis Bio Inc

4.71
USD
-0.405
-7.93%
Dec 18, 15:59 UTC -5
Closed
...

Annovis Bio Inc Profile

About

Annovis Bio Inc. is a clinical-stage, drug platform company addressing neurodegeneration, such as Alzheimer's disease, Parkinson's disease and Alzheimer's in Down Syndrome. Annovis Bio Inc. is headquartered in Berwyn, Pennsylvania.

Info & Links

CEO

Maria Maccecchini

Headquarters

101 Lindenwood Drive, Suite 225
Malvern, PA 19355, UNITED STATES

Auditor

Ernst & Young LLP

Share holders

23

Employees

6

Annovis Bio Inc Statistics

Valuation Measures

Market Capitalization2

64.93M

Enterprise Value

52.29M

Enterprise Value/EBITDA(ttm)

-1.72

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

9.81

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-876.22%

Return on Invested Capital(ttm)

426.22%

Return on Assets(ttm)

-311.00%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-30.40M

Net Income Available to Common(ttm)

-40.94M

Diluted EPS(ttm)

-4.46

Share Statistics

Beta (5Y Monthly)

1.59

52-Week Change

-52.23%

S&P 500 52-Week Change

23.87%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

13.80M

Dividend Yield

0.00%

Float4

9.34M

% Held by Insiders

32.30%

% Held by Institutions

15.83%

Balance Sheet

Total Cash(mrq)

12.64M

Total Cash Per Share(mrq)

0.92

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

2.66%

Quick Ratio(mrq)

2.66%

Book Value Per Share(mrq)

0.53

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.05

Free Cash Flow(ytd)

-13.61M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement